Report: Doctors on FDA Panel Linked to Stent Companies

Bloomberg News is reporting that six doctors who have financial connections to manufacturers of cardiac devices will be serving on an FDA expert panel this week. The panel, which will meet Thursday and Friday in Gaithersburg, Maryland, will be reviewing the link between blood clots and stent implantation. According to Bloomberg News, FDA is waiving conflict of interest rules that restrict panelists from being involved in issues that affect companies in which they have stock interests or contracts.

December 5, 2006

1 Min Read
Report: Doctors on FDA Panel Linked to Stent Companies

This isn't the first time that FDA has selected panelists with financial links to manufacturers that have drugs or devices in the hot seat. The article cites a study by the Center for Science in the Public Interest, which noted that 10 of 32 members that served on the FDA advisory group for Merck's Vioxx were financially connected to makers of the drug. According to the advocacy group, the panel voted 17-15 to put Vioxx back on the market, but FDA ultimately rejected this recommendation.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like